Abstract
Localized scleroderma (also called morphea) is a term encompassing a spectrum of sclerotic autoimmune diseases that primarily affect the skin, but might also involve underlying structures such as the fat, fascia, muscle, and bones. Morphea profundus presenting with atrophic lesions has rarely been reported in the literature. Here we report two cases of morphea profundus presenting with noninflammatory depressed plaques, without any significant skin induration, pigmentation or textural change. Histopathology was confirmatory for morphea profundus.
Highlights
The term „morphea” includes a wide spectrum of clinical entities, varying from localized plaques of only cosmetic importance to deep lesions resulting in considerable morbidity for the patient
Morphea profundus is a rare variant of morphea and it was first described by Whittaker et al in 1989 as a solitary fibrotic plaque
We considered a differential diagnosis of morphea profundus and lupus profundus in our first case
Summary
The term „morphea” includes a wide spectrum of clinical entities, varying from localized plaques of only cosmetic importance to deep lesions resulting in considerable morbidity for the patient. Morphea profundus usually presents with early induration followed by atrophy of subcutaneous tissue and on occasion that of muscle [3]. We report two cases of atrophic morphea profundus presenting without any significant skin induration, pigmentation or textural change, the published literature on this type of presentation is sparse.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.